Stig Streit Jensen joins Gemstone Capital as Senior Advisor
News: Stenocare. The first medical cannabis IPO in Europe.
Investment Opportunities
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Dental Technologies
(undisclosed)
Category: Dental Technologies
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Platform Technology
(undisclosed)
Category: Platform Technology
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Biotechnology
(undisclosed)
Category: Biotechnology
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Artificial Intelligence
(undisclosed)
Category: Artificial Intelligence
STENOCARE A/S
STENOCARE A/S
Listed: STENO (Spotlight)
Category: Medical Cannabis
Listed: STENO (Spotlight)
Category: Medical Cannabis
IPO concluded in October 2018
Risk Intelligence A/S
Risk Intelligence A/S
Listed: RISK (Spotlight)
Category: Security IT
Listed: RISK (Spotlight)
Category: Security IT
IPO concluded in August 2018
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Dental Technologies
(undisclosed)
Category: Dental Technologies
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Platform Technology
(undisclosed)
Category: Platform Technology
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Biotechnology
(undisclosed)
Category: Biotechnology
Pre-IPO funding opportunity
NAME, DK
(undisclosed)
Category: Artificial Intelligence
(undisclosed)
Category: Artificial Intelligence
Who we are
Gemstone Capital is a unique provider of capital and transaction services for tech-companies that have grown to a point where they can choose to sell or grow with funding from an IPO. We are chosen for our industry knowledge, process expertise and investor network.
Left to right: Søren Jonas Bruun and Peter Max.
Newsroom
The Concept
DEDICATED APPROACH
RELEVANT BACKGROUND
VALUABLE RESOURCES
QUALITY SOLUTIONS
Client Track Record
